Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04YJN
|
|||
| Former ID |
DCL000209
|
|||
| Drug Name |
R411
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Phase 2 | [1] | |
| Company |
Roche
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H18O
|
|||
| Canonical SMILES |
CCC(C)(CCC1=CC=CC=C1)O
|
|||
| InChI |
1S/C12H18O/c1-3-12(2,13)10-9-11-7-5-4-6-8-11/h4-8,13H,3,9-10H2,1-2H3
|
|||
| InChIKey |
AEJRTNBCFUOSEM-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 10415-87-9
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discov. 2010 Oct;9(10):804-20. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.